Coherus Oncology, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized
Coherus Oncology, Inc. (CHRS) reported Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized of 2.56 million shares for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized · last filed 2017-03-14
- Coherus Oncology, Inc. share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2016 was 2.56M shares, a 92.45% increase from fiscal 2015.
- Coherus Oncology, Inc. share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2015 was 1.33M shares, a 69.76% decline from fiscal 2014.
- Coherus Oncology, Inc. share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2014 was 4.40M shares, a 177.30% increase from fiscal 2013.
- Coherus Oncology, Inc. share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2013 was 1.59M shares, a 4.32% increase from fiscal 2012.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 12 month |
|---|---|
| 2016-12-31 | 2.56M shares 10-K · filed 2017-03-14 |
| 2015-12-31 | 1.33M shares 10-K · filed 2016-02-29 |
| 2014-12-31 | 4.40M shares 10-K · filed 2015-03-23 |
| 2013-12-31 | 1.59M shares 10-K · filed 2015-03-23 |
| 2012-12-31 | 1.52M shares 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |